Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bennett

Showing results (801-810 of 852) with videos related to

Pageof 86
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2021
Anatomy of an extensively drug-resistant <i>Klebsiella pneumoniae</i> outbreak in Tuscany, ItalyMelissa J Martin, Brendan W Corey, Filomena Sannio, et al.
The Journal of Infectious Diseases|November 28, 2019
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
The Journal of Infectious Diseases|September 25, 2019
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
Vaccine|September 14, 2013
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteersMichele Spring, Jittawadee Murphy, Robin Nielsen, et al.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
Elife|October 29, 2025
Detecting, mapping, and suppressing the spread of a decade-long <i>Pseudomonas aeruginosa</i> nosocomial outbreak with genomicsWilliam Stribling, Lindsey R Hall, Aubrey Powell, et al.
Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Environmental Science & Technology|July 9, 2019
New Training to Meet the Global Phosphorus ChallengeKasper Reitzel, William W Bennett, Nils Berger, et al.
The Journal of Infectious Diseases|June 15, 2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity StudyJason A Regules, Susan B Cicatelli, Jason W Bennett, et al.
Pageof 86

Showing results (801-810 of 852) with videos related to

Sort By:
Pageof 86
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2021
Anatomy of an extensively drug-resistant <i>Klebsiella pneumoniae</i> outbreak in Tuscany, ItalyMelissa J Martin, Brendan W Corey, Filomena Sannio, et al.
The Journal of Infectious Diseases|November 28, 2019
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
The Journal of Infectious Diseases|September 25, 2019
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
Vaccine|September 14, 2013
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteersMichele Spring, Jittawadee Murphy, Robin Nielsen, et al.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
Elife|October 29, 2025
Detecting, mapping, and suppressing the spread of a decade-long <i>Pseudomonas aeruginosa</i> nosocomial outbreak with genomicsWilliam Stribling, Lindsey R Hall, Aubrey Powell, et al.
Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Environmental Science & Technology|July 9, 2019
New Training to Meet the Global Phosphorus ChallengeKasper Reitzel, William W Bennett, Nils Berger, et al.
The Journal of Infectious Diseases|June 15, 2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity StudyJason A Regules, Susan B Cicatelli, Jason W Bennett, et al.
Pageof 86